D-2-hydroxyglutaric aciduria: a case with an intermediate phenotype and prenatal diagnosis of two affected fetuses.
D-2-hydroxyglutaric aciduria (D2HGA) is a rare autosomal recessive disorder with variable clinical expression. The biochemical defect is unknown at present. Previously reported cases have either followed a severe clinical course characterized by neonatal epileptic encephalopathy, cortical blindness, and profound developmental delay, or a mild course characterized by mild developmental delay, manageable epilepsy, and mild hypotonia. To date there has been a clear distinction between these two groups. We report the second case of a child with D2HGA who has followed an intermediate course. She presented in infancy with hypotonia, manageable epilepsy and developed moderate to severe developmental delay, and cortical visual impairment. The proposita had a coarse facial appearance, flat face, broad nasal bridge, up-turned nose, and simple, anteverted ears. These facial anomalies have been noted in other children with D2HGA and this case strengthens the proposed association between this facial phenotype and D2HGA. We also report the third and fourth instances of prenatal diagnosis for D2HGA. At each prenatal diagnosis, an affected fetus was diagnosed on the basis of markedly increased levels of D-2-hydroxyglutaric acid in amniotic fluid.
Clarke
Nigel F
NF
Department of Medical Genetics, Sydney Children's Hospital, Sydney, Australia.
Andrews
Ian
I
Carpenter
Kevin
K
Jakobs
Cornelis
C
van der Knaap
Marjo S
MS
Kirk
Edwin P
EP
D000328:Adult; D000653:Amniotic Fluid / Q000737:chemistry; D019465:Craniofacial Abnormalities / Q000175:diagnosis; D002658:Developmental Disabilities / Q000175:diagnosis*; D004827:Epilepsy / Q000175:diagnosis; D005260:Female; D005977:Glutarates / Q000652:urine*; D006801:Humans; D007223:Infant; D010641:Phenotype; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013577:Syndrome
D005977:Glutarates; C019417:alpha-hydroxyglutarate